In the News

Share
1716 News Items found
A researcher working in an MSK lab
MSK Research Highlights September 18, 2024
New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
Dr. Selwyn Vickers and his wife Janice seen smiling with their four children and son-in-law.
Dr. Selwyn Vickers on Parenting
Selwyn M. Vickers, MD, FACS, the President and CEO of Memorial Sloan Cancer Center, is a renowned pancreatic cancer surgeon, health equity researcher, ...
Education
MSK scientists Daniel Heller and Kayvan Keshari with a confocal microscope.
MSK’s Cancer Engineering Focus Draws Top Scientists
Learn how a new cancer engineering PhD program is attracting leading scientists to come to MSK.
Q&A
Memorial Sloan Kettering infectious disease specialist Monika Shah
What Should I Know about the Flu This Season?
Learn why it's important to get a flu shot this year.
An MSK patient gets a vaccination from a healthcare provider
What To Know About the RSV Vaccines: Who Can Get It, Side Effects, Availability at MSK
RSV is a respiratory illness that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people age 60 and older.
Khaliq Sanda
New, Rare Type of Small Cell Lung Cancer Identified by MSK Research Team
A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.
Microscope image showing lung metastasis
TGF-Beta and RAS Signaling Are Both Required for Lung Cancer Metastasis, Study Finds
MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.
Cody holds his graduation cap
Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer 
Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.
In the Clinic
Drawing of hospital building.
A Future Cancer Hospital in NYC to Meet Rising Need
Learn about MSK's visionary plans for meeting the upcoming surge in cancer cases with state-of-the-art clinical care.
See MSK President and CEO Selwyn Vickers, MD
A Message From Dr. Selwyn Vickers, MSK’s President and CEO
Dear MSK Community,Our knowledge of cancer — what it is and how it progresses — has developed at a staggering pace over the past 20 years. Today, ...